Annovis Bio, Inc. (ANVS)
1.455
-0.24
(-14.41%)
USD |
NYSE |
Sep 03, 10:04
Annovis Bio Market Cap : 61.99M for Sept. 3, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 02, 2026 | 72.43M |
| September 01, 2026 | 72.00M |
| August 31, 2026 | 73.28M |
| August 28, 2026 | 73.28M |
| August 27, 2026 | 77.12M |
| August 26, 2026 | 75.84M |
| August 25, 2026 | 77.54M |
| August 24, 2026 | 74.56M |
| August 21, 2026 | 77.54M |
| August 20, 2026 | 76.27M |
| August 19, 2026 | 78.82M |
| August 18, 2026 | 76.69M |
| August 17, 2026 | 74.13M |
| August 14, 2026 | 78.82M |
| August 13, 2026 | 76.27M |
| August 12, 2026 | 76.69M |
| August 11, 2026 | 80.53M |
| August 10, 2026 | 53.94M |
| August 07, 2026 | 53.65M |
| August 06, 2026 | 53.08M |
| August 05, 2026 | 53.36M |
| August 04, 2026 | 53.36M |
| August 03, 2026 | 49.08M |
| July 31, 2026 | 49.94M |
| July 30, 2026 | 50.51M |
| Date | Value |
|---|---|
| July 29, 2026 | 48.51M |
| July 28, 2026 | 48.23M |
| July 27, 2026 | 47.66M |
| July 24, 2026 | 47.37M |
| July 23, 2026 | 49.94M |
| July 22, 2026 | 49.65M |
| July 21, 2026 | 49.94M |
| July 20, 2026 | 48.23M |
| July 17, 2026 | 49.65M |
| July 16, 2026 | 49.65M |
| July 15, 2026 | 51.37M |
| July 14, 2026 | 48.80M |
| July 13, 2026 | 50.23M |
| July 10, 2026 | 53.08M |
| July 09, 2026 | 55.65M |
| July 08, 2026 | 56.79M |
| July 07, 2026 | 54.79M |
| July 06, 2026 | 56.22M |
| July 02, 2026 | 55.08M |
| July 01, 2026 | 54.79M |
| June 30, 2026 | 53.08M |
| June 29, 2026 | 53.08M |
| June 26, 2026 | 49.08M |
| June 25, 2026 | 47.09M |
| June 24, 2026 | 48.51M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.968B |
| Alnylam Pharmaceuticals, Inc. | 35.58B |
| Anika Therapeutics, Inc. | 282.92M |
| Savara, Inc. | 1.103B |
| Vericel Corp. | 2.075B |
Market Cap Related Metrics
| Price | 1.455 |
| Earnings Yield | -123.2% |